Recognition of the Novel HLA ‐A*02:07:01:07 Allele Through Third‐Generation HLA ‐Targeted Sequencing Technology
HLA · 2025
DOI: 10.1111/tan.70120 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Yuan Yuan Jing und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China. Hauptthemen laut MEDLINE: Alleles, Histocompatibility Testing, Introns, Exons. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 2 Literaturangaben. Gefördert von: Beijing Red Cross Blood Center Research Funds.
Abstract (Originalsprache)
The HLA‐A*02:07:01:07 allele differs from HLA‐A*02:07:01:01 by a single nucleotide change in intron 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China.
ORCID-Profile: Yuan Yuan Jing
Förderung
- Beijing Red Cross Blood Center Research Funds
Zitieren
APA
Jing, Y. Y., Li, D. M., Liu, N., Jia, Y. J., & Sun, T. C. (2025). Recognition of the Novel HLA ‐A*02:07:01:07 Allele Through Third‐Generation HLA ‐Targeted Sequencing Technology. HLA. https://doi.org/10.1111/tan.70120
Vancouver
Jing YY, Li DM, Liu N, Jia YJ, Sun TC. Recognition of the Novel HLA ‐A*02:07:01:07 Allele Through Third‐Generation HLA ‐Targeted Sequencing Technology. HLA. 2025. doi:10.1111/tan.70120
BibTeX
@article{Jing2025,
author = {Jing, Yuan Yuan and Li, Dong Mei and Liu, Na and Jia, Yan Jun and Sun, Tie Cheng},
title = {Recognition of the Novel HLA ‐A*02:07:01:07 Allele Through Third‐Generation HLA ‐Targeted Sequencing Technology},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70120}
}
EUVIMED